HHS 8-K SEC Filing Analysis

Final — all horizons settled through T+60d

HHS ▼ -7.17% at T+60d

SHORT call ✓ call won +7.17% · α vs SPY +18.70% · entry $2.65 → $2.46

Currently $2.53 · +4.53% from $2.65 entry (call sign-flipped)

Entry anchored
Mar 17, 03:59 PM ET
via Databento tick

T+1d

0.00%

call 0.00% · α -0.27%

$2.65

settled 3mo ago

T+5d

-7.55%

call +7.55% · α +6.83%

$2.45

settled 3mo ago

T+20d

+8.30%

call -8.30% · α -2.26%

$2.87

settled 8w ago

T+60d

-7.17%

call +7.17% · α +18.70%

$2.46

settled yesterday

Price Chart

Loading chart...

Executive Summary

Harte Hanks reported declining revenue and earnings for Q4 and full-year 2025, with total revenue down 15.4% YoY in Q4 and 13.9% for the full year. Despite a net income turnaround in Q4 due to prior-year pension charges, core profitability metrics like Adjusted EBITDA fell sharply, indicating weakening operational performance across all segments.

Key Financial Metrics

Revenue

$159.6M

-13.9% YoY

EPS

$-0.11

Actionable Insight

The company's revenue decline across all segments and halving of Adjusted EBITDA suggest fundamental operational challenges. Traders should monitor whether management's 2026 strategy to 'deepen customer relationships' can reverse these trends, especially given the shrinking cash balance.

Key Facts

Q4 2025 revenue was $39.9 million, down 15.4% YoY from $47.1 million
Full-year 2025 revenue was $159.6 million, down 13.9% from $185.2 million
Q4 2025 Adjusted EBITDA was $1.2 million, down from $3.5 million in Q4 2024
Full-year 2025 Adjusted EBITDA was $6.9 million, down from $14.0 million in 2024
Net loss for 2025 was $0.8 million vs. a $30.3 million net loss in 2024, primarily due to $37.5 million in pension plan termination charges in 2024
Cash balance declined to $5.6 million from $9.9 million at year-end 2024

Financial Impact

Revenue declined by $25.6 million for the full year and $7.3 million in Q4. Adjusted EBITDA fell by $7.1 million for the full year.

revenueepsebitdacash

Segment Breakdown

Segment	Revenue	Growth
Revenue Solutions	$35.1M	-30.2%
Customer Care	$50.1M	-5.4%
Fulfillment Logistics	$74.4M	-9.3%

Risk Factors

Continued revenue decline across all business segments
Deteriorating profitability with Adjusted EBITDA down 50% YoY
Cash balance reduced by 43% year-over-year to $5.6 million

Market Snapshot

Exchange

Nasdaq

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

Document	Accession Number
8-K Filing (Primary)	0001628280-26-018959
Document: 0001628280-26-018959-index-headers.html	0001628280-26-018959
Document: 0001628280-26-018959-index.html	0001628280-26-018959
Document: 0001628280-26-018959.txt	0001628280-26-018959

2 reports for HHS

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for HHS — sortable, filterable
	Type				Now
May 14, 2026 29d ago	8-K BEARISH ★ 6/10	$2.80 $2.62	▲ +6.43%	▲ +7.39%	$2.53 (+9.64%)
Mar 18, 2026 12w ago	8-K BEARISH ★ 6/10	$2.65 $2.45	▲ +7.55%	▲ +6.83%	$2.53 (+4.53%)

US Market Status

Market Closed — Opens Mon (48h 51m)

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access